Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy. (2017)

First Author: Smyth E
Attributed to:  CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-16-3142

PubMed Identifier: 28972045

Publication URI: http://europepmc.org/abstract/MED/28972045

Type: Journal Article/Review

Volume: 23

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

Issue: 24

ISSN: 1078-0432